Cardiac bridging integrator 1 gene therapy preserved diastolic function and stabilized calcium-handling machinery in mice hearts stressed by chronic beta agonist stimulation and pressure overload.
Does exogenous cBIN1 gene therapy preserve calcium-handling machinery and diastolic function in mice subjected to chronic stress?
Exogenous cBIN1 gene therapy preserves diastolic function and calcium-handling machinery in a mouse model of chronic stress, suggesting a potential future therapeutic pathway for heart failure with preserved ejection fraction.
Heart failure is an important, and growing, cause of morbidity and mortality. Half of patients with heart failure have preserved ejection fraction, for whom therapeutic options are limited. Here we report that cardiac bridging integrator 1 gene therapy to maintain subcellular membrane compartments within cardiomyocytes can stabilize intracellular distribution of calcium-handling machinery, preserving diastolic function in hearts stressed by chronic beta agonist stimulation and pressure overload. This study identifies that maintenance of intracellular architecture and, in particular, membrane microdomains at t-tubules, is important in the setting of sympathetic stress. Stabilization of membrane microdomains may be a pathway for future therapeutic development.
Liu et al. (Wed,) conducted a other in Heart failure. Cardiac bridging integrator 1 (cBIN1) gene therapy was evaluated on Diastolic function and stabilization of intracellular distribution of calcium-handling machinery. Cardiac bridging integrator 1 gene therapy preserved diastolic function and stabilized calcium-handling machinery in mice hearts stressed by chronic beta agonist stimulation and pressure overload.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: